Table 3.
Relationships between the expressions of the metabolism-related genes and the clinicopathological factors in LUAD.
| Gene symbol | Age (≥65/<65) | Gender (male / female) | Stage (I & II / III & IV) | T stage (T1-T2 / T3-T4) | N stage (N0 / N1-3) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| t | P | t | P | t | P | t | P | t | P | |
| TYMS | -0.048 | 0.962 | -1.628 | 0.105 | -1.534 | 0.128 | 1.242 | 0.218 | -0.271 | 0.787 |
| ALDH2 | -1.829 | 0.069 | -0.762 | 0.447 | 1.032 | 0.304 | 0.348 | 0.729 | 1.326 | 0.186 |
| PKM | -0.081 | 0.935 | -0.544 | 0.587 | -2.908 | 0.004 | -1.822 | 0.075 | -3.051 | 0.003 |
| GNPNAT1 | 0.517 | 0.605 | -2.552 | 0.011 | -2.357 | 0.021 | -1.415 | 0.165 | -1.418 | 0.157 |
| LDHA | 0.72 | 0.472 | -0.976 | 0.33 | -2.647 | 0.01 | -1.884 | 0.066 | -2.508 | 0.013 |
| ENTPD2 | 0.581 | 0.562 | 0.236 | 0.813 | -1.402 | 0.164 | -0.896 | 0.375 | -0.463 | 0.644 |
| NT5E | -0.702 | 0.483 | 1.995 | 0.047 | -1.282 | 0.203 | -1.285 | 0.205 | -0.434 | 0.665 |
| MAOB | -1.79 | 0.075 | 0.629 | 0.53 | 3.918 | 1.14E-04 | 1.99 | 0.05 | 1.09 | 0.277 |
| riskScore | 0.916 | 0.361 | -2.006 | 0.046 | -3.761 | 2.99E-04 | -2.137 | 0.038 | -2.503 | 0.013 |